Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Bolt Biotherapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −8 vs. Q4 2024
- Shares held
- 18.3M
- −329.2K (−1.8%) vs. Q4 2024
- Total value
- $7.33M
- −$2.66M (−26.6%) vs. Q4 2024
- New holders
- 2
- 8 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 40 | $16 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 139 | $56 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 200 | $80 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 906 | $362 | 0.00% | −5−0.5% | Reduced |
| Bank of America Corp | 5,628 | $2.25K | 0.00% | +3+0.1% | Added |
| FMR LLC | 8,100 | $3.24K | 0.00% | −121,154−93.7% | Reduced |
| Tower Research Capital LLC (TRC) | 8,688 | $3.48K | 0.00% | +4,680+116.8% | Added |
| Morgan Stanley | 11,615 | $4.65K | 0.00% | −10.0% | Reduced |
| XTX Topco Ltd | 15,392 | $6.16K | 0.00% | −29,499−65.7% | Reduced |
| StoneX Group Inc. | 15,532 | $6.21K | 0.00% | +15,532 | New |
| Susquehanna International Group, LLP | 21,733 | $8.69K | 0.00% | +21,733 | New |
| Mariner, LLC | 40,000 | $16.0K | 0.00% | +5,000+14.3% | Added |
| Northern Trust Corp | 40,895 | $16.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 47,437 | $19.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 83,893 | $33.6K | 0.00% | +34,922+71.3% | Added |
| UBS Group AG | 111,508 | $44.6K | 0.00% | +45,395+68.7% | Added |
| ADAR1 Capital Management, LLC | 244,966 | $98.0K | 0.02% | 00.0% | Unchanged |
| BlackRock, Inc. | 268,640 | $107.5K | 0.00% | −1,452−0.5% | Reduced |
| Renaissance Technologies LLC | 314,139 | $125.7K | 0.00% | +12,100+4.0% | Added |
| Geode Capital Management, LLC | 375,113 | $150.1K | 0.00% | +34,439+10.1% | Added |
| Pfizer Inc | 626,109 | $250.4K | 0.05% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $287.8K | 0.02% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $419.7K | 0.07% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $466.8K | 0.38% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,169,705 | $467.9K | 0.00% | +102,300+9.6% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $756.6K | 0.61% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,754,437 | $1.10M | 0.08% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,521,291 | $1.41M | 0.19% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,812,773 | $1.53M | 0.08% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −78,961−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −72,402−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −60,200−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −50,020−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −47,025−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,868−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,552−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −20,785−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,355−100.0% | Sold out |